Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

To assess the renal burden of irisin administration, we compared the nontreatment, clinically used drug combinations including bisphosphonate (zoledronic acid) and calcium-absorbing drug (calcitriol), and exogenous irisin in healthy mice (Supplemental Figure 7A) and CKD mice (Figure 7A).

Source: Irisin administration does not increase renal burden.. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The murine preosteoblast cell line MC3T3-E1 subclone 14 was provided by Xiangzhong Zhao (the Affiliated Hospital of Qingdao University, Qingdao, China).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Aerobic exercise prevents renal osteodystrophy via irisin-activated osteoblasts

Study design awaiting verification · JCI Insight · 2025

Original publication title

Aerobic exercise prevents renal osteodystrophy via irisin-activated osteoblasts

Meng Wu; Huilan Li; Xiaoting Sun; Rongrong Zhong; Linli Cai; Ruibo Chen; Madiya Madeniyet; Kana Ren; Zhen Peng; Yujie Yang; Weiqin Chen; Yanling Tu; Miaoxin Lai; Jinxiu Deng; Yuting Wu; Shumin Zhao; Qingyan Ruan; Mei Rao; Sisi Xie; Ying Ye; Jianxin Wan

© 2025 Wu et al.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Renal osteodystrophy is commonly seen in patients with chronic kidney disease (CKD) due to disrupted mineral homeostasis. Given the impaired renal function in these patients, common antiresorptive agents, including bisphosphonates, must be used with caution or even contraindicated. Therefore, an alternative therapy without renal burden to combat renal osteodystrophy is urgently needed. Here, we report that clinically relevant aerobic exercise significantly prevents high-turnover renal osteodystrophy in CKD mice and patients with CKD without compromising renal function. Mechanistically, 4-week aerobic exercise in CKD mice increased expression of skeletal muscle PPARγ coactivator-1α (PGC-1α) and circulating irisin.

Both exercise and irisin administration significantly activated osteoblasts, but not osteoclasts, via integrin αvβ5, thereby conferring bone quality benefits. Removal of irisin-influenced thermogenic adipose tissues or genetic ablation of uncoupling protein 1 did not alter the irisin-conferred antiosteodystrophy effect. Importantly, in a pilot clinical study, 12-week aerobic exercise in patients with high-grade CKD significantly increased circulating irisin and prevented osteodystrophy progression, without detectable renal burden. The combination of irisin and current antiresorptive agents effectively rescued renal osteodystrophy in mice. Our work provides mechanistic insights into the role of exercise and irisin in renal osteodystrophy, and it highlights a clinically relevant, low-cost, kidney-friendly therapy for patients with this devastating disease.

Authors’ abstract

Renal osteodystrophy is commonly seen in patients with chronic kidney disease (CKD) due to disrupted mineral homeostasis. Given the impaired renal function in these patients, common antiresorptive agents, including bisphosphonates, must be used with caution or even contraindicated. Therefore, an alternative therapy without renal burden to combat renal osteodystrophy is urgently needed. Here, we report that clinically relevant aerobic exercise significantly prevents high-turnover renal osteodystrophy in CKD mice and patients with CKD without compromising renal function. Mechanistically, 4-week aerobic exercise in CKD mice increased expression of skeletal muscle PPARγ coactivator-1α (PGC-1α) and circulating irisin.

Both exercise and irisin administration significantly activated osteoblasts, but not osteoclasts, via integrin αvβ5, thereby conferring bone quality benefits. Removal of irisin-influenced thermogenic adipose tissues or genetic ablation of uncoupling protein 1 did not alter the irisin-conferred antiosteodystrophy effect. Importantly, in a pilot clinical study, 12-week aerobic exercise in patients with high-grade CKD significantly increased circulating irisin and prevented osteodystrophy progression, without detectable renal burden. The combination of irisin and current antiresorptive agents effectively rescued renal osteodystrophy in mice. Our work provides mechanistic insights into the role of exercise and irisin in renal osteodystrophy, and it highlights a clinically relevant, low-cost, kidney-friendly therapy for patients with this devastating disease.

Publication and source details

Original title: Aerobic exercise prevents renal osteodystrophy via irisin-activated osteoblasts

Meng Wu; Huilan Li; Xiaoting Sun; Rongrong Zhong; Linli Cai; Ruibo Chen; Madiya Madeniyet; Kana Ren; Zhen Peng; Yujie Yang; Weiqin Chen; Yanling Tu; Miaoxin Lai; Jinxiu Deng; Yuting Wu; Shumin Zhao; Qingyan Ruan; Mei Rao; Sisi Xie; Ying Ye; Jianxin Wan

JCI Insight · 2025

Address correspondence to: Sisi Xie, Department of Cardiology, Basic Scientific Research Center, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, China. Email: 18111010026@fudan.edu.cn. Or to: Ying Ye, Department of Oral Implantology, Stomatological Hospital and Dental School of Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai 200072, China. Email: ying.ye@tongji.edu.cn. Or to: Jianxin Wan, Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Chazhong Road 20, Fuzhou, 350005, China. Email: wanjx@fjmu.edu.cn.

Authorship note: MW, HL, and XS contributed equally to this work and are co: first authors.

© 2025 Wu et al.2025Wu et al.https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Fujian Provincial Health Technology Project2017-2-86The Startup Fund for Scientific Research, Fujian Medical University2017XQ1186the Longyan City Science and Technology Plan Project2022LYF17102the National Natural Science Foundation of ChinaProject No. 82204857the Shanghai Municipal Health Commission202340062the Fujian Province Natural Science Foundation2020J011328the Fujian Provincial Health Technology Project2022QH1500Fujian Provincial Health Technology Project2020GGA080the Longyan City Science and Technology Plan project2022LYF17113S.X. is supported by the Fujian Provincial Health Technology Project (2017-2-86)S.X. is supported by the Startup Fund for Scientific Research, Fujian Medical University (2017XQ1186)S.X. is supported by the Longyan City Science and Technology Plan Project (2022LYF17102)X.S. is supported by the National Natural Science Foundation of China (Project No. 82204857).Y.Ye. is supported by the Shanghai Municipal Health Commission (202340062).Y.W. is supported by the Fujian Province Natural Science Foundation (2020J011328).L.C. is supported by the Fujian Provincial Health Technology Project (2022QH1500).M.W. is supported by Fujian Provincial Health Technology Project (2020GGA080)M.W. is supported by the Longyan City Science and Technology Plan project (2022LYF17113).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:56:21.794869+00:00

DOI: 10.1172/jci.insight.184468 · PMC11949034